Simon Everitt

This inventor holds 25 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 12 EPO patents, primarily in Protein Kinase Inhibitors. Top assignees: Vertex Pharmaceuticals, Inc., Merck Patent Gmbh. Active years: 2005-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Everitt. Retrieved from https://idiyas.com/inventor/simon-everitt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 9)

% Patents Active = 44.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 12 (Patent Applications = 12)

Average Co-Inventor Count = 8.8

ph-index = 16

Forward Citations = 613(Granted Patents)

Location History:

Bucks, GB (2006 - 2012)
Beaconsfields, GB (2009 - 2014)
Oxfordshire, GB (2010 - 2014)
Beaconsfield, GB (2005 - 2016)
Abingdon, GB (2013 - 2024)

Company Filing History:

25 out of 1,168

Vertex Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2005-2024

Loading Chart...

Areas of Expertise:

GCN2 Inhibitors

JAK Kinase

ATR Kinase

Protein Kinase

Azaindoles

Aminopyrimidines

Benzimidazoles

Pyrazole Compounds

Substituted Pyrrolo

Indoleamine 2,3-Dioxygenase

Compositions

Inhibitors

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12084438 - GCN2 inhibitors and uses thereof (2024-09-10),

2. 10988477 - GCN2 inhibitors and uses thereof (2021-04-27),

3. 10793563 - GCN2 inhibitors and uses thereof (2020-10-06),

4. 9499497 - Compounds useful as inhibitors of indoleamine 2,3-dioxygenase (2016-11-22),

5. 9096602 - Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors (2015-08-04),

6. 9073875 - Compounds useful as inhibitors of indoleamine 2,3-dioxygenase (2015-07-07),

7. 8987454 - Azaindoles useful as inhibitors of JAK and other protein kinases (2015-03-24),

8. 8841450 - Compounds useful as inhibitors of ATR kinase (2014-09-23),

9. 8722889 - Azaindoles useful as inhibitors of JAK and other protein kinases (2014-05-13),

10. 8669081 - Compositions useful as inhibitors of protein kinases (2014-03-11),

11. 8642779 - Compositions useful as inhibitors of protein kinases (2014-02-04),

12. 8637511 - Aminopyrimidines useful as kinase inhibitors (2014-01-28),

13. 8501446 - Azaindoles useful as inhibitors of JAK and other protein kinases (2013-08-06),

14. 8188281 - Azaindoles useful as inhibitors of JAK and other protein kinases (2012-05-29),

15. 8129399 - Aminopyrimidines useful as kinase inhibitors (2012-03-06),

Title: The Innovative Mind of Simon Everitt

Introduction: Simon Everitt, a brilliant inventor hailing from Beaconsfield, GB, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Simon Everitt holds several patents in the areas of renewable energy technologies, smart home devices, and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, Simon Everitt has worked with leading tech companies to develop cutting-edge products that have revolutionized the industry. His keen eye for detail and passion for innovation have set him apart as a visionary in his field.

Collaborations: Throughout his career, Simon Everitt has collaborated with top engineers, designers, and researchers to bring his ideas to life. His ability to work seamlessly in multidisciplinary teams has led to the successful implementation of numerous projects.

Conclusion: Simon Everitt's relentless pursuit of innovation and his commitment to creating a sustainable future through technology make him a true pioneer in the world of inventions. His work continues to inspire the next generation of inventors and innovators worldwide.

Profile summary based on public USPTO records.